Cocrystal Pharma, Inc. (COCP) financial statements (2021 and earlier)

Company profile

Business Address 19805 N. CREEK PARKWAY
BOTHELL, WA 98011
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments33731494
Cash and cash equivalents33731494
Restricted cash and investments000    
Receivables11 00(2)(2)
Other undisclosed current assets0001235
Total current assets:348325106
Noncurrent Assets
Operating lease, right-of-use asset01
Property, plant and equipment1000000
Intangible assets, net (including goodwill)19196565656565
Goodwill19196565656565
Deposits noncurrent assets00     
Deferred costs   111 
Other undisclosed noncurrent assets  05353148187
Total noncurrent assets:202066119119214253
TOTAL ASSETS:542969121125224259
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1211131
Accounts payable121   0
Accrued liabilities000 130
Employee-related liabilities000    
Other undisclosed accounts payable and accrued liabilities   1   
Debt000    
Deferred rent credit  0
Derivative instruments and hedges, liabilities00011  
Other undisclosed current liabilities0    48
Total current liabilities:1221279
Noncurrent Liabilities
Long-term debt and lease obligation0101   
Long-term debt, excluding current maturities   1   
Finance lease, liability00
Capital lease obligations0    
Operating lease, liability01
Liabilities, other than long-term debt   14205065
Deferred revenue and credits0   
Deferred tax liabilities, net 14205065
Other undisclosed noncurrent liabilities(0)   000
Total noncurrent liabilities:01015215065
Total liabilities:23216235774
Stockholders' equity
Stockholders' equity attributable to parent, including:5326671051021687
Common stock0000110
Additional paid in capital29726125424323922919
Accumulated other comprehensive income      0
Accumulated deficit(245)(235)(187)(138)(137)(63)(12)
Other undisclosed stockholders' equity attributable to parent      0
Other undisclosed stockholders' equity      178
Total stockholders' equity:532667105102168185
TOTAL LIABILITIES AND EQUITY:542969121125224259

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net  00
Net investment income   (0)0  
Financial services revenue   0
Gross profit:27  000
Operating expenses(12)(55)(63)(8)(106)(54)(6)
Other operating expense, net
(Other Expenses)
      (0)
Other undisclosed operating income (loss)   0(0) (0)
Operating loss:(10)(48)(63)(8)(106)(54)(6)
Nonoperating income (expense)(0)0012(11)11
Investment income, nonoperating      6
Other nonoperating income (expense)    2(11)6
Interest and debt expense(0) (0)    
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes0 0   (6)
Loss from continuing operations before income taxes:(10)(48)(63)(7)(104)(65)(0)
Income tax expense (benefit)  1472915(0)
Net loss:(10)(48)(49)(1)(75)(50)(0)
Other undisclosed net income attributable to parent      0
Net loss available to common stockholders, diluted:(10)(48)(49)(1)(75)(50)(0)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(10)(48)(49)(1)(75)(50)(0)
Comprehensive loss:(10)(48)(49)(1)(75)(50)(0)
Other undisclosed comprehensive income, net of tax, attributable to parent      0
Comprehensive income (loss), net of tax, attributable to parent:(10)(48)(49)(1)(75)(50)0

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: